384 related articles for article (PubMed ID: 23804138)
21. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
22. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
23. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.
Amo T; Kawanishi N; Uchida M; Fujita H; Oyanagi E; Utsumi T; Ogino T; Inoue K; Shuin T; Utsumi K; Sasaki J
Cell Biochem Funct; 2009 Dec; 27(8):503-15. PubMed ID: 19735078
[TBL] [Abstract][Full Text] [Related]
25. Natural Compounds Modulate Drug Transporter Mediated Oral Cancer Treatment.
Yang H; Wei YC; Li WC; Chen HY; Lin HY; Chiang CP; Chen HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32957726
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract][Full Text] [Related]
27. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
29. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
30. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
31. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
32. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
[TBL] [Abstract][Full Text] [Related]
33. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Yoshioka E; Chelakkot VS; Licursi M; Rutihinda SG; Som J; Derwish L; King JJ; Pongnopparat T; Mearow K; Larijani M; Dorward AM; Hirasawa K
Theranostics; 2018; 8(8):2134-2146. PubMed ID: 29721068
[TBL] [Abstract][Full Text] [Related]
35. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.
Zhao SG; Chen XF; Wang LG; Yang G; Han DY; Teng L; Yang MC; Wang DY; Shi C; Liu YH; Zheng BJ; Shi CB; Gao X; Rainov NG
Ann Surg Oncol; 2013 Dec; 20(13):4379-88. PubMed ID: 22688660
[TBL] [Abstract][Full Text] [Related]
37. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma.
Moon YH; Park JH; Kim SA; Lee JB; Ahn SG; Yoon JH
Head Neck; 2010 Sep; 32(9):1136-42. PubMed ID: 19953630
[TBL] [Abstract][Full Text] [Related]
38. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
39. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
40. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
